Literature DB >> 33964157

Kinetics of γH2AX and phospho-histone H3 following pulse treatment of TK6 cells provides insights into clastogenic activity.

Steven M Bryce1, Stephen D Dertinger1, Jeffrey C Bemis1.   

Abstract

The desire for in vitro genotoxicity assays to provide higher information content, especially regarding chemicals' predominant genotoxic mode of action, has led to the development of a novel multiplexed assay available under the trade name MultiFlow®. We report here on an experimental design variation that provides further insight into clastogens' genotoxic activity. First, the standard MultiFlow DNA Damage Assay-p53, γ H2AX, phospho-histone H3 was used with human TK6 lymphoblastoid cells that were exposed for 24 continuous hours to each of 50 reference clastogens. This initial analysis correctly identified 48/50 compounds as clastogenic. These 48 compounds were then evaluated using a short-term, 'pulse' treatment protocol whereby cells were exposed to test chemical for 4 h, a centrifugation/washout step was performed, and cells were allowed to recover for 20 h. MultiFlow analyses were accomplished at 4 and 24 h. The γ H2AX and phospho-histone H3 biomarkers were found to exhibit distinct differences in terms of their persistence across chemical classes. Unsupervised hierarchical clustering analysis identified three groups. Examination of the compounds within these groups showed one cluster primarily consisting of alkylators that directly target DNA. The other two groups were dominated by non-DNA alkylators and included anti-metabolites, oxidative stress inducers and chemicals that inhibit DNA-processing enzymes. These results are encouraging, as they suggest that a simple follow-up test for in vitro clastogens provides mechanistic insights into their genotoxic activity. This type of information will contribute to improve decision-making and help guide further testing.
© The Author(s) 2021. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33964157      PMCID: PMC8445823          DOI: 10.1093/mutage/geab014

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   2.954


  54 in total

1.  2,4-Diaminotoluene (2,4-DAT)-induced DNA damage, DNA repair and micronucleus formation in the human hepatoma cell line HepG2.

Authors:  Isabelle Séverin; Adeline Jondeau; Laurence Dahbi; Marie-Christine Chagnon
Journal:  Toxicology       Date:  2005-09-15       Impact factor: 4.221

2.  In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU.

Authors:  Elmar Gocke; Lutz Müller
Journal:  Mutat Res       Date:  2009-04-17       Impact factor: 2.433

Review 3.  Validation of the γH2AX biomarker for genotoxicity assessment: a review.

Authors:  B Kopp; L Khoury; Marc Audebert
Journal:  Arch Toxicol       Date:  2019-07-09       Impact factor: 5.153

4.  Mutagenic and carcinogenic potential of menadione.

Authors:  C Cojocel; L Novotny; A Vachalkova
Journal:  Neoplasma       Date:  2006       Impact factor: 2.575

5.  Aneugen Versus Clastogen Evaluation and Oxidative Stress-Related Mode-of-Action Assessment of Genotoxic Compounds Using the ToxTracker Reporter Assay.

Authors:  Inger Brandsma; Nynke Moelijker; Remco Derr; Giel Hendriks
Journal:  Toxicol Sci       Date:  2020-09-01       Impact factor: 4.849

6.  Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis.

Authors:  W Voigt; S Matsui; M B Yin; W C Burhans; H Minderman; Y M Rustum
Journal:  Anticancer Res       Date:  1998 Sep-Oct       Impact factor: 2.480

7.  Effects of zidovudine and stavudine on mitochondrial DNA of differentiating 3T3-F442a cells are not associated with imbalanced deoxynucleotide pools.

Authors:  Matthew D Lynx; Darcy D LaClair; Edward E McKee
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

8.  Molecular cytogenetic evaluation of the mechanism of micronuclei formation induced by camptothecin, topotecan, and irinotecan.

Authors:  Sabry M Attia; Abdulaziz M Aleisa; Saleh A Bakheet; Abdulaziz A Al-Yahya; Salim S Al-Rejaie; Abdelkader E Ashour; Othman A Al-Shabanah
Journal:  Environ Mol Mutagen       Date:  2009-03       Impact factor: 3.216

9.  The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth.

Authors:  Christopher M Cabello; Warner B Bair; Sarah D Lamore; Stephanie Ley; Alexandra S Bause; Sara Azimian; Georg T Wondrak
Journal:  Free Radic Biol Med       Date:  2008-11-01       Impact factor: 7.376

10.  Comet assay measures of DNA damage as biomarkers of irinotecan response in colorectal cancer in vitro and in vivo.

Authors:  Joanna P Wood; Andrew J O Smith; Karen J Bowman; Anne L Thomas; George D D Jones
Journal:  Cancer Med       Date:  2015-06-23       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.